I-Mab Appoints BD SVP

I-Mab has appointment of Fernando J. Sallés, Ph.D., CLP, as senior vice president, head of U.S. & EU Business Development. In this newly created role, Dr. Sallés will initially be responsible for leading global out-licensing efforts and co-development partnerships/strategic alliances with large pharma and biopharma companies to expedite the development and market entry of the company’s products. Dr. Sallés will report to Dr. Jingwu Zang, Founder and Honorary Chairman of I-Mab, as a member of the senior executive team.

Dr. Sallés has more than 28 years of experience in academic and corporate research and development, including 19 years of building extensive networks in the pharma and biotech industries. He has extensive experience across the entire range of business development activities in several large, global pharma/biotech organizations, including in pipeline strategy, portfolio management, due diligence, transaction negotiations, in- and out-licenses, collaborations and M&A.

"Dr. Sallés is an industry veteran with broad experience across the business development lifecycle. We are very pleased to welcome Dr. Sallés to join our journey where he will lead our strategic efforts to broaden our global out-licensing and co-development partnerships of our internally developed innovative assets," said Dr. Jingwu Zang, I-Mab’s Founder and Honorary Chairman of the Board.

Prior to joining I-Mab, Dr. Sallés provided business development expertise to buy-side and sell-side biopharma clients at Pteropsida, LLC. Before Pteropsida, Dr. Sallés was Vice President, Head of Global Search at Teva Pharmaceuticals, where he developed search organization strategies to complement and fill Teva’s branded R&D portfolio, including the identification and diligence on more than 50 executed licenses and M&A agreements, and out-licensing assets totaling an estimated $1 billion in value.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the articles,

please email: Julia.Zhang@imsinoexpo.com to motify or remove the content.